Q4-FY26 · Edward Manis
We concluded the year 26 on a very strong note with Q4 marking our highest ever quarterly revenue and AIDA performance for the full year.
Rossari Biotech · tone and specificity signals across the available quarters.
Language signals
We concluded the year 26 on a very strong note with Q4 marking our highest ever quarterly revenue and AIDA performance for the full year.
Our focus remains on strengthening customer relationships, expanding the product market, improving market penetration, and building scale in relevant chemistries and applications.
The target is to actually get debt free by in the next 18 months but I think that the time is there but currently the plan is to keep bringing down our debts over the next 18 months.